Related references
Note: Only part of the references are listed.EGCG inhibits growth of human pancreatic tumors orthotopically implanted in Balb C nude mice through modulation of FKHRL1/FOXO3a and neuropilin
Sharmila Shankar et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2013)
Brain Insulin Resistance and Deficiency as Therapeutic Targets in Alzheimers Disease
Suzanne M. de la Monte
Current Alzheimer Research (2012)
Suppression of Free Fatty Acid-Induced Insulin Resistance by Phytopolyphenols in C2C12 Mouse Skeletal Muscle Cells
Yea-Tzy Deng et al.
JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY (2012)
An anti-diabetes agent protects the mouse brain from defective insulin signaling caused by Alzheimer's disease-associated Aβ oligomers
Theresa R. Bomfim et al.
JOURNAL OF CLINICAL INVESTIGATION (2012)
Demonstrated brain insulin resistance in Alzheimer's disease patients is associated with IGF-1 resistance, IRS-1 dysregulation, and cognitive decline
Konrad Talbot et al.
JOURNAL OF CLINICAL INVESTIGATION (2012)
Dementia is associated with Insulin Resistance in patients with Parkinson's Disease
Domenico Bosco et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2012)
High-fat diet-induced obesity and insulin resistance were ameliorated via enhanced fecal bile acid excretion in tumor necrosis factor-alpha receptor knockout mice
Mayumi Yamato et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2012)
Insulin resistance in the nervous system
Bhumsoo Kim et al.
TRENDS IN ENDOCRINOLOGY AND METABOLISM (2012)
Epigallocatechin-3-O-gallate (EGCG) attenuates FFAs-induced peripheral insulin resistance through AMPK pathway and insulin signaling pathway in vivo
Yan Li et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2011)
Attenuation of the cardiac inflammatory changes and lipid anomalies by (-)-epigallocatechin-gallate in cigarette smoke-exposed rats
A. Gokulakrisnan et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2011)
Impaired miR-146a expression links subclinical inflammation and insulin resistance in Type 2 diabetes
M. Balasubramanyam et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2011)
Green Tea (-)-Epigallocatechin-3-Gallate Inhibits β-Amyloid-Induced Cognitive Dysfunction through Modification of Secretase Activity via Inhibition of ERK and NF-κB Pathways in Mice
Jae Woong Lee et al.
JOURNAL OF NUTRITION (2009)
Green tea epigallocatechin-3-gallate (EGCG) reduces β-amyloid mediated cognitive impairment and modulates tau pathology in Alzheimer transgenic mice
Kavon Rezai-Zadeh et al.
BRAIN RESEARCH (2008)
Insulin receptor signaling regulates synapse number, dendritic plasticity, and circuit function in vivo
Shu-Ling Chiu et al.
NEURON (2008)
A mouse model to study tau pathology related with tau phosphorylation and assembly
Tobias Engel et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2007)
Soluble protein oligomers in neurodegeneration:: lessons from the Alzheimer's amyloid β-peptide
Christian Haass et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2007)
Green tea epigallocatechin-3-gallate (EGCG) modulates amyloid precursor protein cleavage and reduces cerebral amyloidosis in Alzheimer transgenic mice
K Rezai-Zadeh et al.
JOURNAL OF NEUROSCIENCE (2005)
Positive and negative regulation of insulin signaling through IRS-1 phosphorylation
P Gual et al.
BIOCHIMIE (2005)
Effects of green tea on gene expression of hepatic gluconeogenic enzymes in vivo
Y Koyama et al.
PLANTA MEDICA (2004)
A central role for JNK in obesity and insulin resistance
J Hirosumi et al.
NATURE (2002)
Share Paper
